S.King’s 9-9-05 Letter to Shareholders “As an example, we have seen a significant amount of interest building in the anti-phospholipid therapy program and particularly in Tarvacin over the past year from potential partners as the program has entered into clinical trials.”
WOW! Nine years have past and still nothing. Just goes to show SK's words are meaningless. Now at $1.49. Luckily we haven't hit $50 yet but soon! Looks like Wall Street tuning out mgmt or they haven't seen a copy of the 2009 catalyst yet. I guess Wall Street has read the boy who cried wolf story.
Price on 9/9/2005 was $5.60 which represents about a -70% return over nine years. Nice! All imo.
News 
Market Data 
Discover 
